Study of the Safety of Orencia in Japanese Children and Adolescents With Active Juvenile Arthritis of Unknown Origin
NCT03466814 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 82
Last updated 2022-06-16
Summary
Observational study of abatacept in the treatment of JIA in Japan.
Conditions
- Undifferentiated Arthritis
Interventions
- OTHER
-
Non-Interventional
Non-Interventional
Sponsors & Collaborators
-
Ono Pharmaceutical Co. Ltd
collaborator INDUSTRY - lead INDUSTRY
Principal Investigators
-
Bristol-Myers Squibb · Bristol-Myers Squibb
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-04-06
- Primary Completion
- 2021-07-21
- Completion
- 2021-07-21
Countries
- Japan
More Related Trials
-
Dose Escalation With Remicade® and Orencia®
NCT01141413 ·Status: COMPLETED
-
Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis
NCT01717846 ·Status: WITHDRAWN ·Phase: PHASE4
-
Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT00962741 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Kineret® in Patients With Systemic Juvenile Idiopathic Arthritis (SJIA)
NCT03932344 ·Status: COMPLETED
-
Predictors of Adherence to Orencia
NCT01136707 ·Status: COMPLETED
-
Description of Joint Population and Assessment of Impact on Health Status of Orencia in Patients With Rheumatoid Arthritis in France. A Database Analysis Based on SFR's ORA Long-term Cohort Study
NCT01694693 ·Status: WITHDRAWN
-
Efficacy and Safety of Etanercept in Active RA Despite Methotrexate Therapy in Japan
NCT00688103 ·Status: COMPLETED ·Phase: PHASE4
-
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
NCT05782335 ·Status: RECRUITING
-
Effective Dose of Etanercept in Patients Treated for Juvenile Idiopathic Arthritis
NCT02030613 ·Status: COMPLETED ·Phase: NA
-
Treatment Tapering in JIA With Inactive Disease
NCT02840175 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate
NCT01399281 ·Status: UNKNOWN
-
Korean Post-marketing Surveillance for Orencia®
NCT01583244 ·Status: COMPLETED
-
Long-term Experience With Abatacept SC in Routine Clinical Practice
NCT02090556 ·Status: COMPLETED
-
Study Evaluating the Efficacy of Enbrel (Etanercept) in Subjects in Japan
NCT00503503 ·Status: COMPLETED
-
Safety and Effectiveness of Abatacept in Psoriatic Arthritis Participants
NCT03419143 ·Status: COMPLETED
-
Long Term Experience With Abatacept in Routine Clinical Practice
NCT02109666 ·Status: COMPLETED
-
Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia
NCT02778906 ·Status: COMPLETED ·Phase: PHASE3
-
Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan
NCT00503139 ·Status: COMPLETED
-
Kineret in the Treatment of Rheumatoid Arthritis
NCT02915094 ·Status: COMPLETED
-
Prediction of Abatacept Discontinuation Using Test Reflecting Immunological Remission in Rheumatoid Arthritis
NCT04343378 ·Status: COMPLETED
-
Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
NCT01421069 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)
NCT03780959 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan
NCT02335606 ·Status: COMPLETED
-
Juvenile Arthritis Quantitative Imaging
NCT02684695 ·Status: RECRUITING
-
A Single Dose Of Compound SB-681323 Compared To Prednisolone On A Protein That Is an Indicator For Rheumatoid Arthritis
NCT00134693 ·Status: COMPLETED ·Phase: PHASE2